![William John Jenkins](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
William John Jenkins
Directeur/Membre du Conseil chez
Apitope Technology (Bristol) Ltd.
Fortune : 83 625 $ au 31/05/2026
Profil
William John Jenkins is currently Principal at William Jenkins Pharma Consulting since 1999, Independent Non-Executive Director at Apitope Technology (Bristol) Ltd. since 2018, and Director at AlloCyte Pharmaceuticals AG.
Former roles include Director at Tanox, Inc., Director at Monogram Biosciences, Inc. from 2000 to 2009, Non-Executive Director at Consort Medical Ltd. from 2009 to 2011, Director at BioVersys AG, Non-Executive Director at Eurand NV, Non-Executive Director at BTG Ltd. from 2002 to 2011, Independent Director at Ablynx NV, Director at Eurand Pharmaceutical Holdings BV, Independent Non-Executive Director at Apitope International NV, Director-Executive Board at Vaximm AG, Director at Allecra Therapeutics GmbH, Director at Acambis Research Ltd., Member-Supervisory Board at Evotec SE in 2008, Head-Clinical & Regulatory Affairs at Ciba-Geigy AG, Head-Worldwide Clinical Research at Glaxo Group Research Ltd. from 1988 to 1992, and Head-Clinical Development & Regulatory Affairs at Novartis Pharma AG.
Education includes undergraduate, graduate, and doctorate degrees from the University of Cambridge and a graduate degree from the University of London.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
BIOVERSYS AG 0,04% | 31/12/2025 | 2 420 ( 0,04% ) | 83 625 $ | 31/05/2026 |
Postes actifs de William John Jenkins
| Sociétés | Poste | Début |
|---|---|---|
William Jenkins Pharma Consulting | Corporate Officer/Principal | 01/01/1999 |
AlloCyte Pharmaceuticals AG
 AlloCyte Pharmaceuticals AG Pharmaceuticals: MajorHealth Technology Develops small molecule drugs for immune-mediated diseases | Directeur/Membre du Conseil | - |
Apitope Technology (Bristol) Ltd.
 Apitope Technology (Bristol) Ltd. Miscellaneous Commercial ServicesCommercial Services Develops therapeutic vaccines and diagnostics for autoimmune and allergic diseases | Directeur/Membre du Conseil | 08/03/2018 |
Anciens postes connus de William John Jenkins
| Sociétés | Poste | Fin |
|---|---|---|
| BIOVERSYS AG | Directeur/Membre du Conseil | 30/04/2026 |
| BTG | Directeur/Membre du Conseil | 04/02/2011 |
Monogram Biosciences, Inc.
 Monogram Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services for HIV treatment | Directeur/Membre du Conseil | 04/08/2009 |
| EVOTEC SE | Directeur/Membre du Conseil | 01/01/2008 |
Tanox, Inc.
 Tanox, Inc. Pharmaceuticals: MajorHealth Technology Develops antibody and pharmaceutical solutions used for the treatment of allergic diseases | Directeur/Membre du Conseil | 03/08/2007 |
Formation de William John Jenkins
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
52
Relations au 1er degré
21
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 21 |
|---|---|
Tanox, Inc.
Tanox, Inc. Pharmaceuticals: MajorHealth Technology Develops antibody and pharmaceutical solutions used for the treatment of allergic diseases | Health Technology |
Monogram Biosciences, Inc.
Monogram Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services for HIV treatment | Commercial Services |
Consort Medical Ltd.
 Consort Medical Ltd. MiscellaneousMiscellaneous Functions as an investment holding company | Miscellaneous |
Eurand NV
 Eurand NV Pharmaceuticals: MajorHealth Technology Manufactures and commercializes enhanced pharmaceutical and biopharmaceutical products | Health Technology |
Evotec SE
 Evotec SE Miscellaneous Commercial ServicesCommercial Services Provides drug discovery and development services | Commercial Services |
BTG Ltd.
 BTG Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and supplies drugs used in the treatment of neurological disorders | Health Technology |
Ciba-Geigy AG
 Ciba-Geigy AG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of London
 University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ablynx NV
 Ablynx NV BiotechnologyHealth Technology Develops and produces antibodies | Health Technology |
Eurand Pharmaceutical Holdings BV | |
Glaxo Group Research Ltd. | |
William Jenkins Pharma Consulting | |
Apitope International NV
 Apitope International NV BiotechnologyHealth Technology Develops therapeutic vaccines | Health Technology |
Apitope Technology (Bristol) Ltd.
Apitope Technology (Bristol) Ltd. Miscellaneous Commercial ServicesCommercial Services Develops therapeutic vaccines and diagnostics for autoimmune and allergic diseases | Commercial Services |
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Vaximm AG
 Vaximm AG Miscellaneous Commercial ServicesCommercial Services Develops immunotherapies for cancer treatment | Commercial Services |
Acambis Research Ltd.
 Acambis Research Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and experimental development on natural sciences and engineering | Commercial Services |
Allecra Therapeutics GmbH
 Allecra Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which manufactures pharmaceuticals to combat multi drug-resistant bacterial infections | Health Technology |
AlloCyte Pharmaceuticals AG
AlloCyte Pharmaceuticals AG Pharmaceuticals: MajorHealth Technology Develops small molecule drugs for immune-mediated diseases | Health Technology |
BioVersys AG
 BioVersys AG BiotechnologyHealth Technology Engages in research and development of small molecules on novel bacterial targets with application of AMR & antibiotic drugs | Health Technology |
